213 related articles for article (PubMed ID: 11232608)
1. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study.
Deisenhofer I; Kolb C; Ndrepepa G; Schreieck J; Karch M; Schmieder S; Zrenner B; Schmitt C
J Cardiovasc Electrophysiol; 2001 Feb; 12(2):134-42. PubMed ID: 11232608
[TBL] [Abstract][Full Text] [Related]
2. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
[TBL] [Abstract][Full Text] [Related]
3. Dual chamber implantable cardioverter defibrillator benefits and limitations.
Fan K; Lee K; Lau CP
J Interv Card Electrophysiol; 1999 Oct; 3(3):239-45. PubMed ID: 10490480
[TBL] [Abstract][Full Text] [Related]
4. Avoiding inappropriate therapy of single-lead implantable cardioverter-defibrillator by using atrial-sensing electrodes.
Kurt M; Jathanna N; Babady M; Schmidt J; Müller P; Gerguri S; Clasen L; Bejinariu A; Kelm M; Fürnkranz A; Makimoto H
J Cardiovasc Electrophysiol; 2018 Dec; 29(12):1682-1689. PubMed ID: 30203568
[TBL] [Abstract][Full Text] [Related]
5. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms.
Theuns DA; Klootwijk AP; Goedhart DM; Jordaens LJ
J Am Coll Cardiol; 2004 Dec; 44(12):2362-7. PubMed ID: 15607399
[TBL] [Abstract][Full Text] [Related]
6. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.
Gasparini M; Lunati MG; Proclemer A; Arenal A; Kloppe A; Martínez Ferrer JB; Hersi AS; Gulaj M; Wijffels MCE; Santi E; Manotta L; Varma N
JACC Clin Electrophysiol; 2017 Nov; 3(11):1275-1282. PubMed ID: 29759624
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator].
Kazmierczak J; Tavernier R; De Sutter J; Jordaens L
Pol Merkur Lekarski; 2000 Aug; 9(50):522-6. PubMed ID: 11081315
[TBL] [Abstract][Full Text] [Related]
8. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
[TBL] [Abstract][Full Text] [Related]
10. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
[TBL] [Abstract][Full Text] [Related]
11. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.
Schwab JO; Bonnemeier H; Kleemann T; Brachmann J; Fischer S; Birkenhauer F; Eberhardt F
Clin Res Cardiol; 2015 Dec; 104(12):1021-32. PubMed ID: 26002818
[TBL] [Abstract][Full Text] [Related]
12. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
13. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
Proclemer A; Della Bella P; Facchin D; Fattore L; Carbucicchio C; Tondo C; Lunati M; Vecchi MR; Petz E; Zecchin M
Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
[TBL] [Abstract][Full Text] [Related]
14. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
[TBL] [Abstract][Full Text] [Related]
15. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
[TBL] [Abstract][Full Text] [Related]
16. New ICD-technologies: first clinical experience with dual-chamber sensing for differentiation of supraventricular tachyarrhythmias.
Osswald S; Cron TA; Sterns L; Alt E; Stotts L; Coenen M
Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):292-5. PubMed ID: 9474691
[TBL] [Abstract][Full Text] [Related]
17. Dual chamber arrhythmia detection in the implantable cardioverter defibrillator.
Dijkman B; Wellens HJ
J Cardiovasc Electrophysiol; 2000 Oct; 11(10):1105-15. PubMed ID: 11059974
[TBL] [Abstract][Full Text] [Related]
18. Is modification of the VVI backup mode in implantable cardioverter-defibrillators from St Jude medical required due to increased risk of inappropriate shocks?
Philbert BT; Tfelt-Hansen J; Jacobsen PK; Pehrson S; Svendsen JH; Jøns C; Petersen HH
Europace; 2017 May; 19(5):808-811. PubMed ID: 27247013
[TBL] [Abstract][Full Text] [Related]
19. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between ventricular and supraventricular tachycardia by dual chamber cardioverter defibrillators: importance of the atrial sensing function.
Israel CW; Grönefeld G; Iscolo N; Stöppler C; Hohnloser SH
Pacing Clin Electrophysiol; 2001 Feb; 24(2):183-90. PubMed ID: 11270697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
